CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2016; 74(05): 388-395
DOI: 10.1590/0004-282X20160042
ARTICLE

Surgical outcomes of the endoscopic endonasal transsphenoidal approach for large and giant pituitary adenomas: institutional experience with special attention to approach-related complications

Resultados cirúrgicos do acesso endonasal endoscópico transesfenoidal para adenomas hipofisários grandes e gigantes: experiência institucional com ênfase às complicações relacionadas ao acesso cirúrgico
Edson Rocha Constantino
Universidade Federal Fluminense, Hospital Universitário Antçnio Pedro, Divisão de Neurocirurgia, Niterói RJ, Brazil.
,
Rafael Leal
Universidade Federal Fluminense, Hospital Universitário Antçnio Pedro, Divisão de Neurocirurgia, Niterói RJ, Brazil.
,
Christian Cândido Ferreira
Universidade Federal Fluminense, Hospital Universitário Antçnio Pedro, Divisão de Neurocirurgia, Niterói RJ, Brazil.
,
Marcus André Acioly
Universidade Federal Fluminense, Hospital Universitário Antçnio Pedro, Divisão de Neurocirurgia, Niterói RJ, Brazil.
,
José Alberto Landeiro
Universidade Federal Fluminense, Hospital Universitário Antçnio Pedro, Divisão de Neurocirurgia, Niterói RJ, Brazil.
› Author Affiliations

ABSTRACT

Objective In this study, we investigate our institutional experience of patients who underwent endoscopic endonasal transsphenoidal approach for treatment of large and giant pituitary adenomas emphasizing the surgical results and approach-related complications.

Method The authors reviewed 28 consecutive patients who underwent surgery between March, 2010 and March, 2014.

Results The mean preoperative tumor diameter was 4.6 cm. Gross-total resection was achieved in 14.3%, near-total in 10.7%, subtotal in 39.3%, and partial in 35.7%. Nine patients experienced improvement in visual acuity, while one patient worsened. The most common complications were transient diabetes insipidus (53%), new pituitary deficit (35.7%), endonasal adhesions (21.4%), and cerebrospinal fluid leak (17.8%). Surgical mortality was 7.1%.

Conclusions Endoscopic endonasal transsphenoidal surgery is a valuable treatment option for large or giant pituitary adenomas, which results in high rates of surgical decompression of cerebrovascular structures.

RESUMO

Objetivo Neste manuscrito investigamos a experiência institucional com o acesso endonasal endoscópico transesfenoidal no tratamento de adenomas hipofisários grandes e gigantes com ênfase às complicações relacionadas ao acesso cirúrgico.

Método Foram incluídos neste estudo 28 pacientes consecutivos submetidos à cirurgia entre Março de 2010 e Março de 2014.

Resultados O diâmetro médio pré-operatório dos tumores era 4,6 cm. Uma ressecção total foi obtida em 14,3%; quase total, em 10,7%; subtotal, em 39,3% e parcial, em 35,7%. Nove pacientes evoluíram com melhora na acuidade visual, enquanto um paciente apresentou piora da função visual. As complicações mais comuns foram diabetes insipidus transitório (53%), novo défice hipofisário (35,7%), sinéquias endonasais (21,4%) e fistula liquórica (17,8%). A mortalidade cirúrgica foi 7,1%.

Conclusões A cirurgia por via endonasal endoscópica transesfenoidal é uma opção terapêutica extremamente útil para adenomas hipofisários grandes e gigantes, a resultar numa significativa descompressão das estruturas cerebrovasculares.



Publication History

Received: 05 January 2016

Accepted: 17 February 2016

Article published online:
06 September 2023

© 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Guiot J, Rougerie J, Fourestier M, Fournier A, Comoy C, Vulmiere J et al. [Intracranial endoscopic explorations]. Presse Med. 1963;71:1225-8. French.
  • 2 Xue-Fei S, Yong-Fei W, Shi-Qi L, Jing-Song W, Yao Z, Ying M et al. Microsurgical treatment for giant and irregular pituitary adenomas in a series of 54 consecutive patients. Br J Neurosurg. 2008;22(5):636-48. doi:10.1080/02688690802346083
  • 3 Berker M, Hazer DB, Yücel T, Gürlek A, Cila A, Aldur M, et al. Complications of endoscopic surgery of the pituitary adenomas: analysis of 570 patients and review of the literature. Pituitary. 2012;15(3):288-300. doi:10.1007/s11102-011-0368-2
  • 4 Santos RP, Zymberg ST, Abucham Filho JZ, Gregório LC, Weckx LLM. Endoscopic transnasal approach to sellar tumors. Rev Bras Otorrinolaringol. 2007;73(4):463-75. doi:10.1590/S0034-72992007000400005
  • 5 Agrawal A, Cincu R, Goel A. Current concepts and controversies in the management of non-functioning giant pituitary macroadenomas. Clin Neurol Neurosurg. 2007;109(8):645-50. doi:10.1016/j.clineuro.2007.06.007
  • 6 Gondim JA, Almeida JP, Albuquerque LA, Gomes EF, Schops M. Giant pituitary adenomas: surgical outcomes of 50 cases operated on by the endonasal endoscopic approach. World Neurosurg. 2014;82(1-2):e281-90. doi:10.1016/j.wneu.2013.08.028
  • 7 Komotar RJ, Starke RM, Raper DM, Anand VK, Schwartz TH. Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas. Pituitary. 2012;15(2):150-9. doi:10.1007/s11102-011-0359-3
  • 8 Chabot JD, Chakraborty S, Imbarrato G, Dehdashti AR. Evaluation of outcomes after endoscopic endonasal surgery for large and giant pituitary macroadenoma: a retrospective review of 39 consecutive patients. World Neurosurg. 2015;84(4):978-88. doi:10.1016/j.wneu.2015.06.007
  • 9 Cappabianca P, Cavallo LM, de Divitiis O, de Angelis M, Chiaramonte C, Solari D. Endoscopic Endonasal Extended Approaches for the Management of Large Pituitary Adenomas. Neurosurg Clin N Am. 2015;26(3):323-31. doi:10.1016/j.nec.2015.03.007
  • 10 Juraschka K, Khan OH, Godoy BL, Monsalves E, Kilian A, Krischek B, et al. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection. J Neurosurg. 2014;121(1):75-83. doi:10.3171/2014.3.JNS131679
  • 11 Cusimano MD, Kan P, Nassiri F, Anderson J, Goguen J, Vanek I, et al. Outcomes of surgically treated giant pituitary tumours. Can J Neurol Sci. 2012;39(4):446-57. doi:10.1017/S0317167100013950
  • 12 Landeiro JA, Fonseca EO, Monnerat AL, Taboada GF, Cabral GA, Antunes F. Nonfunctioning giant pituitary adenomas: invasiveness and recurrence. Surg Neurol Int. 2015;6:179. doi 10.4103/2152-7806.170536
  • 13 Di Maio S, Cavallo LM, Esposito F, Stagno V, Corriero OV, Cappabianca P. Extended endoscopic endonasal approach for selected pituitary adenomas: early experience. J Neurosurg. 2011;114(2):345-53. doi:10.3171/2010.9.JNS10262
  • 14 Hofstetter CP, Nanaszko MJ, Mubita LL, Tsiouris J, Anand VK, Schwartz TH. Volumetric classification of pituitary macroadenomas predicts outcome and morbidity following endoscopic endonasal transsphenoidal surgery. Pituitary. 2012;15(3):450-63. doi:10.1007/s11102-011-0350-z
  • 15 Koutourousiou M, Gardner PA, Fernandez-Miranda JC, Paluzzi A, Wang EW, Snyderman CH. Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations. J Neurosurg. 2013;118(3):621-31. doi:10.3171/2012.11.JNS121190
  • 16 Nakao N, Itakura T. Surgical outcome of the endoscopic endonasal approach for non-functioning giant pituitary adenoma. J Clin Neurosci. 2011;18(1):71-5. doi:10.1016/j.jocn.2010.04.049
  • 17 Hardy J. Transphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg. 1969;16:185-217.
  • 18 Mohr G, Hardy J, Comtois R, Beauregard H. Surgical management of giant pituitary adenomas. Can J Neurol Sci. 1990;17(1):62-6.
  • 19 Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva F et al. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab. 2010;95(7):3141-8. doi:10.1210/jc.2009-2670
  • 20 Colao A, Attanasio R, Pivonello R, Cappabianca P, Cavallo LM, Lasio G, et al. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J Clin Endocrinol Metab. 2006;91(1):85-92. doi:10.1210/jc.2005-1208
  • 21 Jho HD, Carrau RL. Endoscopic endonasal transsphenoidal surgery: experience with 50 patients. J Neurosurg. 1997;87(1):44-51. doi:10.3171/jns.1997.87.1.0044
  • 22 Tabaee A, Anand VK, Barrón Y, Hiltzik DH, Brown SM, Kacker A, et al. Endoscopic pituitary surgery: a systematic review and meta-analysis. J Neurosurg. 2009;111(3):545-54. doi:10.3171/2007.12.17635
  • 23 Cappabianca P, Cavallo LM, Esposito F, De Divitiis O, Messina A, De Divitiis E. Extended endoscopic endonasal approach to the midline skull base: the evolving role of transsphenoidal surgery. Adv Tech Stand Neurosurg. 2008;33:151-99. doi:10.1007/978-3-211-72283-1
  • 24 Paiva Neto MA, Vandergrift A, Fatemi N, Gorgulho AA, Desalles AA, Cohan P et al. Endonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas. Clin Endocrinol (Oxf). 2010;72(4):512-9. doi:10.1111/j.1365-2265.2009.03665.x
  • 25 McLaughlin N, Eisenberg AA, Cohan P, Chaloner CB, Kelly DF. Value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery. J Neurosurg. 2013;118(3):613-20. doi:10.3171/2012.11.JNS112020
  • 26 Zhao B, Wei YK, Li GL, Li YN, Yao Y, Kang J, et al. Extended transsphenoidal approach for pituitary adenomas invading the anterior cranial base, cavernous sinus, and clivus: a single-center experience with 126 consecutive cases. J Neurosurg. 2010;112(1):108-17. doi:10.3171/2009.3.JNS0929
  • 27 Little AS, Kelly D, Milligan J, Griffiths C, Prevedello DM, Carrau RL, et al. Predictors of sinonasal quality of life and nasal morbidity after fully endoscopic transsphenoidal surgery. J Neurosurg. 2015;122(6):1458-65. doi:10.3171/2014.10.JNS141624